Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment

Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopathic iliopsoas hematoma is a very rarely described...

Descripción completa

Detalles Bibliográficos
Autores principales: Sottilotta, Gianluca, Mangano, Carmelo, Basile, Rosa, Falcone, Carmela, Luise, Francesca, Megalizzi, Demetrio, Nicolò, Giovanna Maria, Oriana, Vincenzo, Piromalli, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161851/
https://www.ncbi.nlm.nih.gov/pubmed/34104443
http://dx.doi.org/10.1177/2050313X211016991
_version_ 1783700591104491520
author Sottilotta, Gianluca
Mangano, Carmelo
Basile, Rosa
Falcone, Carmela
Luise, Francesca
Megalizzi, Demetrio
Nicolò, Giovanna Maria
Oriana, Vincenzo
Piromalli, Angela
author_facet Sottilotta, Gianluca
Mangano, Carmelo
Basile, Rosa
Falcone, Carmela
Luise, Francesca
Megalizzi, Demetrio
Nicolò, Giovanna Maria
Oriana, Vincenzo
Piromalli, Angela
author_sort Sottilotta, Gianluca
collection PubMed
description Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopathic iliopsoas hematoma is a very rarely described hemorrhagic complication in patients with COVID-19. We report here two cases of iliopsoas hematoma in male patients with COVID-19 and being treated with heparin.
format Online
Article
Text
id pubmed-8161851
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81618512021-06-07 Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment Sottilotta, Gianluca Mangano, Carmelo Basile, Rosa Falcone, Carmela Luise, Francesca Megalizzi, Demetrio Nicolò, Giovanna Maria Oriana, Vincenzo Piromalli, Angela SAGE Open Med Case Rep Case Report Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopathic iliopsoas hematoma is a very rarely described hemorrhagic complication in patients with COVID-19. We report here two cases of iliopsoas hematoma in male patients with COVID-19 and being treated with heparin. SAGE Publications 2021-05-26 /pmc/articles/PMC8161851/ /pubmed/34104443 http://dx.doi.org/10.1177/2050313X211016991 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Sottilotta, Gianluca
Mangano, Carmelo
Basile, Rosa
Falcone, Carmela
Luise, Francesca
Megalizzi, Demetrio
Nicolò, Giovanna Maria
Oriana, Vincenzo
Piromalli, Angela
Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
title Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
title_full Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
title_fullStr Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
title_full_unstemmed Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
title_short Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
title_sort iliopsoas hematoma in patients with covid-19 on low-molecular-weight heparin treatment
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161851/
https://www.ncbi.nlm.nih.gov/pubmed/34104443
http://dx.doi.org/10.1177/2050313X211016991
work_keys_str_mv AT sottilottagianluca iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT manganocarmelo iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT basilerosa iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT falconecarmela iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT luisefrancesca iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT megalizzidemetrio iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT nicologiovannamaria iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT orianavincenzo iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment
AT piromalliangela iliopsoashematomainpatientswithcovid19onlowmolecularweightheparintreatment

Ejemplares similares